Louis received PhD in Pharmaceutical Sciences

Louis successfully defended his PhD research entitled “Inhibiting PI3K/Akt to Enhance Brain Uptake of Anticancer Agents in Glioblastoma.” Louis joined the BHL in 2019 as an MD/PhD student studying the overexpression of drug-efflux pumps in glioblastoma and the development of a novel therapeutic strategy to increase brain uptake of anticancer drugs. Louis will now continue finishing his MD in the College of Medicine at the University of Kentucky. Congratulations, Louis!

Recent Posts

BHL Holiday Party

The BHL Annual Holiday Party brought the team together to mark the end of the year. We shared food, spent time together, and played a white elephant gift exchange. It was a nice opportunity to connect outside the lab!

Read More »
December 20, 2025

BHL Winter Retreat

We held our annual BHL Winter Retreat to reflect on our achievements in 2025 and provide an outlook on 2026. Every lab member gave a presentation, we discussed and shared ideas, and set goals for the coming months.

Read More »
December 19, 2025

Bjoern attended the AES Meeting in Atlanta

Bjoern attended the AES Annual Meeting in Atlanta and presented a poster on the team’s findings on CBD in epilepsy. Bjoern met with former lab members and colleagues, and learned about current advances in epilepsy research and emerging therapies.

Read More »
December 5, 2025